Lantheus Holdings, Inc. (LNTH)

Lantheus Holdings, Inc. engages in the provision of diagnostic imaging and nuclear medicine products. The firm develops products that help healthcare professionals in patient management and outcomes and assists clinicians with the detection of cardiovascular disease. It operates through the U.S. and International geographical segments. The U.S. segment produces and markets products, radiopharmacies, PMFs, integrated delivery networks, hospitals, clinics, and group practices throughout the United States. The International segment offers direct distribution in Canada and third-party distribution relationships in Europe, Canada, Australia, Asia-Pacific, Central America, and South America. The company was founded in 1956 and is headquartered in Bedford, MA.

Address

331 TREBLE COVE ROAD
NORTH BILLERICA, MA 01862

Founded

1956

Number of Employees

834

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )
- $97 $601 $2,855 $3,394 $2,558 $2,128 $2,130 $82,763 $14,431 $20,676 $13,163
Average Price - $7.47 $9.47 $13.37 $17.50 $24.13 $15.10 $19.94 $55.81 $74.10 $65.41 $46.49
# Shares Purchased - 13,020 63,513 213,579 193,879 106,008 140,917 106,807 1,483,067 194,762 316,127 283,168
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - 1,305.6% 1,009.0% 685.5% 499.9% 335.2% 595.2% 426.5% 88.2% 41.7% 60.5% 125.9%
S&P 500 Return to Date - 173.0% 168.6% 129.7% 104.9% 93.1% 74.8% 31.7% 37.3% 31.3% 7.4% 85.2%
Excess Total Return - 1,132.7% 840.4% 555.7% 395.0% 242.1% 520.4% 394.9% 50.9% 10.4% 53.1% 40.7%
Quartile Rank
Percentile Rank - 99% 98% 98% 97% 95% 98% 99% 90% 79% 98% 88%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)